tiprankstipranks
Alterola Biotech (ABTI)
OTHER OTC:ABTI
US Market

Alterola Biotech (ABTI) Financial Statements

11 Followers

Alterola Biotech Financial Overview

Alterola Biotech's market cap is currently ―. The company's EPS TTM is $-0.002; its P/E ratio is -10.00; Alterola Biotech is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Sep 23Jun 23Mar 23Dec 22
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ 367.53K$ -44.96K$ 14.53K$ -490.97K$ -540.62K
EBITDA$ 367.53K$ -44.96K$ 14.53K$ -490.97K$ -540.62K
Net Income Common Stockholders$ -2.01M$ -44.96K$ -718.83K$ -219.89K$ -546.45K
Balance Sheet-
Cash Cash Equivalents And Short Term Investments$ 2.57K$ 9.10K$ 36.55K$ 8.89K$ 12.82K
Total Assets$ 3.59K$ 497.21K$ 12.69M$ 12.38M$ 12.21M
Total Debt$ 244.06K$ 1.55M$ 1.37M$ 1.41M$ 151.25K
Net Debt$ 241.49K$ 1.54M$ 1.34M$ 1.41M$ 138.44K
Total Liabilities$ 1.36M$ 2.52M$ 2.33M$ 2.28M$ 1.97M
Stockholders Equity$ -1.35M$ -2.02M$ 10.36M$ 10.10M$ 10.24M
Cash Flow-
Free Cash Flow$ -1.18M$ -122.16K$ -75.47K$ 116.71K$ -793.28K
Operating Cash Flow$ -1.18M$ -122.16K$ -75.47K$ 116.71K$ -793.28K
Investing Cash Flow$ -35.00K$ 53.90K$ -18.90K$ -157.95K$ 18.15K
Financing Cash Flow$ 1.21M$ 7.08K$ 68.45K$ 118.75K$ 796.46K
Currency in USD

Alterola Biotech Earnings and Revenue History

Alterola Biotech Debt to Assets

Alterola Biotech Cash Flow

Alterola Biotech Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis